Baze, a subscription platform that ships personalized vitamin supplement packages based on home blood test results, has raised $6 million in Series A funding. Supplement and wellness product manufacturer Nature’s Way headed the investment.
WHAT THEY DO
Looking to cut back on unnecessary supplement consumption and the costs it ensues, Baze’s direct-to-consumer service first tests the user to see...
Tasso, a Seattle-based startup working on bringing blood testing to the home via a wearable patch-like device, has raised $6.1 million in Series A funding. Vertical Venture Partners led the round, with additional participation from TechStars and Cedars Sinai. This is the first major VC round for the company, but it has previously been supported by $13.1 million in grant funding from DARPA, NIH,...
